BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29652520)

  • 21. A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung.
    Zhao YD; Chu L; Lin K; Granton E; Yin L; Peng J; Hsin M; Wu L; Yu A; Waddell T; Keshavjee S; Granton J; de Perrot M
    PLoS One; 2015; 10(8):e0134958. PubMed ID: 26317340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
    Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.
    Christou H; Yoshida A; Arthur V; Morita T; Kourembanas S
    Am J Respir Cell Mol Biol; 1998 Jun; 18(6):768-76. PubMed ID: 9618381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.
    Ricard N; Tu L; Le Hiress M; Huertas A; Phan C; Thuillet R; Sattler C; Fadel E; Seferian A; Montani D; Dorfmüller P; Humbert M; Guignabert C
    Circulation; 2014 Apr; 129(15):1586-97. PubMed ID: 24481949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.
    Liu J; Wang W; Wang L; Chen S; Tian B; Huang K; Corrigan CJ; Ying S; Wang W; Wang C
    EBioMedicine; 2018 Jul; 33():196-210. PubMed ID: 29921553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiological consequences of hemolysis. Role of cell-free hemoglobin].
    Misztal T; Tomasiak M
    Postepy Hig Med Dosw (Online); 2011 Sep; 65():627-39. PubMed ID: 22100795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension.
    Federti E; Matté A; Ghigo A; Andolfo I; James C; Siciliano A; Leboeuf C; Janin A; Manna F; Choi SY; Iolascon A; Beneduce E; Melisi D; Kim DW; Levi S; De Franceschi L
    Free Radic Biol Med; 2017 Nov; 112():376-386. PubMed ID: 28801243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
    Aiello RJ; Bourassa PA; Zhang Q; Dubins J; Goldberg DR; De Lombaert S; Humbert M; Guignabert C; Cavasin MA; McKinsey TA; Paralkar V
    J Pharmacol Exp Ther; 2017 Feb; 360(2):267-279. PubMed ID: 27927914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
    Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
    Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation.
    Imamura M; Luo B; Limbird J; Vitello A; Oka M; Ivy DD; McMurtry IF; Garat CV; Fallon MB; Carter EP
    J Appl Physiol (1985); 2005 Feb; 98(2):739-47. PubMed ID: 15516365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
    Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
    Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
    Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.
    Mohsenin V
    Sleep Breath; 2016 Sep; 20(3):1059-67. PubMed ID: 27154628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia inducible factor-1 alpha correlates the expression of heme oxygenase 1 gene in pulmonary arteries of rat with hypoxia-induced pulmonary hypertension.
    Li QF; Dai AG
    Acta Biochim Biophys Sin (Shanghai); 2004 Feb; 36(2):133-40. PubMed ID: 14970910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
    Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
    Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.